Bird Flu :: Indonesia reports 2 avian bird flu cases

Two Indonesians have been hospitalized in less than a week with H5N1 avian influenza infections, the country?s first in more than a month, according to news services. Indonesia?s health ministry told Bloomberg News that a 14-year-old boy who tested positive for the H5N1 virus was being treated at Persahabatan Hospital in Jakarta after showing flulike symptoms on Jan_1.

Bird Flu :: Indonesia bird flu case tested positive

The Indonesian Health Ministry confirms that a 14-year-old boy has tested positive for bird flu in Indonesia, the country’s first case of the virus in almost two months. The boy, from Tangerang in West Java, was hospitalised in Jakarta after he suffered from bird-flu-like symptoms on Jan_1.

Bird Flu :: NIH starts clinical trial of H5N1 DNA vaccine

US Federal officials have announced the launch of the first clinical trial of an H5N1 avian influenza vaccine made from a piece of the virus’s DNA rather than from the whole virus, an approach that may facilitate faster vaccine production.

Bird Flu :: WHO Chan worries about bird flu pandemic

The new director-general of the World Health Organization, Margaret Chan, warns the threat of an influenza pandemic has not receded. She urges countries around the world to prepare for a pandemic that has the potential to kill millions.

Bird Flu :: Ramifications of widespread use of Tamiflu

Widespread use of the antiviral Tamiflu to fight pandemic avian flu in humans could actually lead to the development of what public health officials hope to avoid??drug-resistant strains of the virus in wild birds. British researchers at the Centre for Ecology and Hydrology in Oxford have released findings in the January 2007 issue of Environmental Health Perspectives (EHP) that demonstrate how Tamiflu?s persistence in wastewater and river water could affect the waterfowl that drink from those water sources.

Bird Flu :: NIAID DNA vaccine for H5N1 avian influenza enters human trial

The first human trial of a DNA vaccine designed to prevent H5N1 avian influenza infection began on December 21, 2006, when the vaccine was administered to the first volunteer at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD. Scientists from the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), one of the NIH Institutes, designed the vaccine. The vaccine does not contain any infectious material from the influenza virus.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack